Jim Cramer's Top Takeaways: Blackhawk, Horizon Pharmaceuticals, CyberArk
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.
Blackhawk Network (HAWK) : In his first exclusive interview, Cramer sat down with Bill Tauscher, chairman and CEO of Blackhawk, the leader in gift card purchasing.
Tauscher said he was shocked by the market's reaction to their quarterly earnings, which were quite positive. He said they remain very pleased with their results and their growth trajectory.
One of the products that has Tauscher very excited is a new gift card with partner Stockpile.com, that allows people to purchase shares of stocks and ETFs, just as they would a normal gift card. Tauscher explained that the cards get purchased as normal, then the recipient goes to the website, creates and account and can purchase stocks for just 99 cents a transaction. The new stock gift cards are currently being tested at 1,500 select locations.
Tauscher also touted Blackhawk's international investments, which continue to bear fruit, and also his company's foray into gift cards as incentives for employees. He said more and more companies are rewarding employees with gift cards and more and more employees are choosing gift cards for their rewards.
Horizon Pharmaceuticals (HZNP) - Get Report : In his second interview, Cramer also sat down with Tim Walbert, chairman, president and CEO of Horizon Pharmaceuticals, which just released a 34-cent-a-share earnings beat that sent shares soaring 6.1% in an otherwise difficult environment for many biotech stocks.
Walbert started off by explaining that unlike Valeant Pharmaceuticals (VRX) , which has come under fire for its relationships with specialty pharmacies, Horizon has one goal, getting patients the prescriptions that doctors prescribe.
Walbert continued by noting that 96% of all Horizon patients pay less than $10 for each of their seven medications currently on the market.
Horizon also continues to innovate, and Walbert said that his company has spent hundreds of millions on offering gastrointestinal protections for their drugs that sometimes cause GI problems.
CyberArk Software (CYBR) - Get Report : For his third, and final, interview, Cramer also sat down with Udi Mokady, president and CEO of CyberArk, the software company that's seen its shares fall over 32% over the past six weeks.
Mokady said that the information security market continues to thrive, and securing companies from the inside continues to be an area where CyberArk is the leader. He said what was once only for financial companies is now expanding to every company.
When asked about what a manufacturing company would want to protect, Mokady explained that while manufacturing may not have millions of customers' credit card numbers, they do have intellectual property and sensitive employee and supplier information that needs to be protected. No company wants to see their name in the papers next to the word "hack."
CyberArk also continues to make inroads into the lucrative federal space, Mokady said, and his company sees the federal sector as a long-term market.
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.